Infectious Disease Surveillance || Communication of Information About Surveillance: Part 1: Media Communication of Information about Infectious Disease Surveillance and Outbreaks
- 作者M'ikanatha, Nkuchia M.; Lynfield, Ruth; Van Beneden, Chris A.; de Valk, Henriette
- 文件大小232.49KB
- 发表时间2007
- DOI10.1002/9780470692097.ch32
- 页码419-431
Meta-Methodology: Conducting and Reporting Meta-AnalysesTurner, J. Rick; Durham, Todd A. · The Journal of Clinical Hypertension · 2014
Must New Drugs Be Superior to Those Already Available? The Role of Noninferiority Clinical TrialsTurner, J. Rick; Durham, Todd A. · The Journal of Clinical Hypertension · 2015
Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance (Turner/Integrated) || FrontmatterTurner, J. Rick; Durham, Todd A. · 2008
Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance (Turner/Integrated) || IndexTurner, J. Rick; Durham, Todd A. · 2008
Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance (Turner/Integrated) || ReferencesTurner, J. Rick; Durham, Todd A. · 2008
Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance (Turner/Integrated) || Nonclinical DevelopmentTurner, J. Rick; Durham, Todd A. · 2008
Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance (Turner/Integrated) || Generalized Cardiac SafetyTurner, J. Rick; Durham, Todd A. · 2008
Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance (Turner/Integrated) || General Safety AssessmentsTurner, J. Rick; Durham, Todd A. · 2008